Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07447206 · ClinicalTrials.gov registry record · Phase 2
Vascular Intervention Strategies Trial for Alzheimer's
A Phase 2 study, sponsored by University of Southern California.
- Not yet
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT07447206 is a Phase 2 study that has not yet begun recruiting, run by University of Southern California. The registered enrollment target is 10 participants.
The verdict
NCT07447206, a Phase 2 study, has not yet begun recruiting, sponsored by University of Southern California.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The proposed pharmacist-led study is a feasibility pilot trial for the management of vascular risk factors of hypertension and hypercholesterolemia in 10 APOE ε4 carriers, 50-75, at-risk for dementia. All participants will receive angiotensin receptor blockers (ARBs) for high blood pressure, and hydrophilic statins (or a non-statin alternative) for high cholesterol over a six-month period.
Interventions
- DRUG Angiotensin Receptor Blockers (ARBs)
- DRUG Hydrophilic Statins or Non-Statin Alternative
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-05 |
| Est. Completion | 2028-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07447206
The ClinicalTrials.gov registry entry for NCT07447206 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Angiotensin Receptor Blockers (ARBs) is the first listed.
NCT07447206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07447206 about?
NCT07447206 is a clinical study titled "Vascular Intervention Strategies Trial for Alzheimer's". The proposed pharmacist-led study is a feasibility pilot trial for the management of vascular risk factors of hypertension and hypercholesterolemia in 10 APOE ε4 carriers, 50-75, at-risk for dementia. All participants will receive angiotensin receptor blockers (ARBs) for high blood pressure, and hyd...
What is the current status of trial NCT07447206?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2026-05. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07447206?
The interventions under investigation include: Angiotensin Receptor Blockers (ARBs) (DRUG), Hydrophilic Statins or Non-Statin Alternative (DRUG).
Who is sponsoring clinical trial NCT07447206?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.